Christopher A Hunter Selected Research

Christopher A Hunter Research Topics

Disease

75	Infections 01/2022 - 03/2002
27	Inflammation (Inflammations) 10/2021 - 10/2002
21	Toxoplasmosis 01/2021 - 03/2002
8	Neoplasms (Cancer) 10/2019 - 02/2003
5	Persistent Infection 07/2015 - 10/2002
4	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 08/2005
3	Parasitic Diseases (Parasitic Disease) 11/2021 - 10/2004
3	Colitis 01/2019 - 06/2008
3	Malaria 01/2013 - 08/2010
2	Cryptosporidiosis 12/2021 - 10/2019
2	COVID-19 10/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021 - 02/2020
2	Fibrosis (Cirrhosis) 01/2020 - 12/2014
2	Dysbiosis 01/2019 - 01/2019
2	Multiple Sclerosis 01/2019 - 05/2006
2	Crohn Disease (Crohn's Disease) 01/2019 - 06/2008
2	Leishmaniasis 01/2016 - 10/2009
2	Vitiligo 04/2015 - 02/2014
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2012 - 05/2009
2	Autoimmune Diseases (Autoimmune Disease) 05/2009 - 05/2006
1	Ischemia 11/2022
1	Anemia 10/2021
1	Viral Pneumonia 10/2021
1	Pneumonia (Pneumonitis) 10/2021
1	Sepsis (Septicemia) 10/2021
1	Parkinson Disease (Parkinson's Disease) 07/2021
1	Ureteral Obstruction 01/2020
1	Cytokine Release Syndrome 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Bacterial Infections (Bacterial Infection) 11/2019
1	Necrosis 11/2019
1	Pediatric Crohn's disease 01/2019
1	Foodborne Diseases 01/2019
1	Paramyxoviridae Infections (Parainfluenza) 01/2017
1	Dengue (Dengue Fever) 01/2017
1	Zika Virus Infection 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2016

Drug/Important Bio-Agent (IBA)

40	CytokinesIBA 11/2022 - 04/2002
27	Interleukin-27 (Interleukin 27)IBA 11/2021 - 01/2004
21	Interleukin-12 (IL 12)IBA 11/2019 - 04/2002
13	Interleukin-10 (Interleukin 10)IBA 01/2021 - 04/2002
11	AntigensIBA 01/2022 - 12/2004
10	Proteins (Proteins, Gene)FDA Link 07/2021 - 07/2002
10	Interleukin-17 (Interleukin 17)IBA 01/2020 - 07/2005
7	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2002
6	Interferon-gamma (Interferon, gamma)IBA 01/2019 - 09/2002
6	NF-kappa B (NF-kB)IBA 08/2005 - 05/2002
5	InterferonsIBA 01/2022 - 09/2012
5	Interleukin-23 (Interleukin 23)IBA 06/2008 - 08/2004
4	LigandsIBA 07/2021 - 05/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2010
3	Interleukin-18 (Interleukin 18)IBA 12/2021 - 01/2003
3	Messenger RNA (mRNA)IBA 01/2020 - 09/2002
3	InterleukinsIBA 12/2014 - 04/2006
3	Interleukin-12 Subunit p40IBA 05/2013 - 03/2002
3	Interleukin-2 (IL2)IBA 01/2013 - 09/2002
3	Interleukin-13IBA 04/2006 - 10/2002
2	InflammasomesIBA 12/2021 - 11/2019
2	SynucleinsIBA 07/2021 - 01/2019
2	ChemokinesIBA 01/2020 - 06/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 06/2013
2	CollagenIBA 01/2020 - 12/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 11/2003
2	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2019 - 01/2014
2	EnzymesIBA 01/2019 - 12/2009
2	AntibodiesIBA 01/2017 - 05/2006
2	Chemokine CXCL10IBA 04/2015 - 02/2014
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2015 - 07/2013
2	VaccinesIBA 04/2012 - 08/2010
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 12/2009 - 09/2002
2	Interleukin-5 (Interleukin 5)IBA 04/2006 - 01/2005
2	Interleukin-4 (Interleukin 4)IBA 01/2005 - 04/2004
1	Chemotactic FactorsIBA 11/2022
1	Mitochondrial DNA (mtDNA)IBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	Caspase 8 (Caspase-8)IBA 11/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	CarbocyaninesIBA 10/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2019
1	Coloring Agents (Dyes)IBA 10/2019
1	EstersIBA 10/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	AnionsIBA 01/2019
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	NitratesIBA 01/2019
1	Interferon Regulatory FactorsIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	NucleosidesIBA 01/2017
1	nanchangmycinIBA 01/2017
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 10/2016
1	blinatumomabIBA 10/2016

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2006
2	Ligation 06/2005 - 07/2004
1	Intravenous Injections 10/2019
1	Diet Therapy (Therapy, Diet) 01/2019
1	Enteral Nutrition (Feeding, Tube) 01/2019